Logo
O

Oncimmune Limited & EarlyCDT-Lung

53 employees

Oncimmune engaged in developing and commercializing its EarlyCDT platform technology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Cancer
Autoimmune Disease
Systemic Lupus
Bioinformatics
Systemic Sclerosis
Immunotherapy
Lung cancer detection
Commercial
Lung cancer
COVID-19
Pulmonary nodules
Immuno oncology
Infectious disease
Companion diagnostics
Autoantibodies
Early cancer detection

Date founded

2006

Funding rounds raised

Total raised

$119K

from 3 investors over 3 rounds

O

Oncimmune Limited & EarlyCDT-Lung raised $119K on February 1, 2017

Investors: SBRI Healthcare

O

Oncimmune Limited & EarlyCDT-Lung raised undisclosed on December 31, 2014

Investors: Claret Capital Partners

O

Oncimmune Limited & EarlyCDT-Lung raised undisclosed on October 1, 2007

Investors: Balderton Capital

FAQ